Modera Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Sell
2,515
-306
-11% -$40.3K ﹤0.01% 535
2026
Q1
$393K Sell
2,821
-1,974
-41% -$276K ﹤0.01% 476
2025
Q4
$589K Buy
4,795
+284
+6% +$34.5K 0.01% 426
2025
Q3
$501K Buy
4,511
+31
+0.7% +$3.52K 0.01% 457
2025
Q2
$497K Buy
4,480
+112
+3% +$11.9K 0.01% 450
2025
Q1
$489K Sell
4,368
-655
-13% -$67.6K 0.01% 443
2024
Q4
$464K Buy
5,023
+179
+4% +$16.1K 0.01% 457
2024
Q3
$406K Sell
4,844
-471
-9% -$35.9K 0.01% 445
2024
Q2
$365K Sell
5,315
-32
-0.6% -$2.14K 0.01% 443
2024
Q1
$392K Buy
5,347
+129
+2% +$9.92K 0.01% 430
2023
Q4
$423K Buy
5,218
+542
+12% +$42.2K 0.01% 397
2023
Q3
$350K Buy
4,676
+66
+1% +$5.08K 0.01% 421
2023
Q2
$355K Buy
4,610
+1,165
+34% +$92.9K 0.01% 440
2023
Q1
$286K Sell
3,445
-344
-9% -$28.5K 0.01% 292
2022
Q4
$325K Buy
3,789
+14
+0.4% +$1.11K 0.01% 271
2022
Q3
$233K Buy
3,775
+7
+0.2% +$441 0.01% 281
2022
Q2
$233K Sell
3,768
-18
-0.5% -$1.11K 0.01% 295
2022
Q1
$225K Sell
3,786
-662
-15% -$42.3K 0.01% 326
2021
Q4
$323K Buy
4,448
+43
+1% +$2.96K 0.01% 379
2021
Q3
$308K Buy
+4,405
New +$309K 0.02% 203
2018
Q4
Sell
-2,667
Closed -$206K 139
2018
Q3
$206K Buy
+2,667
New +$201K 0.04% 136

Other funds holding GILD

Modera Wealth Management's GILD Position: Q2 2026 in Review

Modera Wealth Management reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $40.3K and leaving 2,515 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #535.

Modera Wealth Management first reported a position in GILD in Q3 2018 and has held it in 21 quarters since. The position peaked at $589K in Q4 2025. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Modera Wealth Management held 2,515 shares of Gilead Sciences worth $318K as of Q2 2026.
  • Modera Wealth Management sold 306 Gilead Sciences shares in Q2 2026, an estimated $40.3K.
  • Gilead Sciences made up ﹤0.01% of Modera Wealth Management's portfolio in Q2 2026, its #535 holding.
  • Modera Wealth Management first reported a position in Gilead Sciences in Q3 2018 and has held it in 21 quarters since.
  • Modera Wealth Management's Gilead Sciences position peaked at $589K in Q4 2025.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Modera Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.